Literature DB >> 24835707

Evaluating the costs and benefits of using combination therapies.

Philip M Clarke1, Alex B Avery2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24835707     DOI： 10.5694/mja14.00199

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  2 in total

1.  How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).

Authors:  Andrea L Schaffer; Sallie-Anne Pearson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

2.  Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?

Authors:  Louise E Bartlett; Nicole Pratt; Elizabeth E Roughead
Journal:  Br J Clin Pharmacol       Date:  2016-09-29       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.